The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019

Rui Liu, Qingfeng Ma, Huan Han, Hanwen Su, Fang Liu, Kailang Wu, Wei Wang, Chengliang Zhu, Rui Liu, Qingfeng Ma, Huan Han, Hanwen Su, Fang Liu, Kailang Wu, Wei Wang, Chengliang Zhu

Abstract

Background Among patients with coronavirus disease 2019 (COVID-19), the cases of a significant proportion of patients are severe. A viral nucleic acid test is used for the diagnosis of COVID-19, and some hematological indicators have been used in the auxiliary diagnosis and identification of the severity of COVID-19. Regarding body fluid samples, except for being used for nucleic acid testing, the relationship between COVID-19 and routine body fluid parameters is not known. Our aim was to investigate the value of urine biochemical parameters in the prediction of the severity of COVID-19. Methods A total of 119 patients with COVID-19 were enrolled at Renmin Hospital of Wuhan University. According to the severity of COVID-19, the patients were divided into three groups (moderate 67, severe 42 and critical 10), and 45 healthy persons were enrolled in the same period as healthy controls. The relationship between the results of urine biochemical parameters and the severity of COVID-19 was analyzed. Results The positive rates of urine occult blood (BLOOD) and proteinuria (PRO) were higher in COVID-19 patients than in healthy controls (p < 0.05); the urine specific gravity (SG) value was lower in patients than in healthy controls (p < 0.05), and the urine potential of hydrogen (pH) value was higher in patients than in healthy controls (p < 0.01). The positive rates of urine glucose (GLU-U) and PRO in the severe and critical groups were higher than those in the moderate group (p < 0.01 and p < 0.05, respectively); other biochemical parameters of urine were not associated with the severity of COVID-19. Conclusions Some urine biochemical parameters are different between patients with severe acute respiratory syndrome (SARS)-CoV-2 and healthy controls, and GLU-U and PRO may be helpful for the differentiation of COVID-19 severity.

Keywords: COVID-19; SARS-CoV-2; urine biochemical parameters.

References

    1. Bian Y, Zhou J, Liao M. Research progress of coronavirus non-structural proteins. Chin J Anim Infect Dis 2013;21:67–74.
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
    1. Fung TS, Liu DX. Human coronavirus: host-pathogen interaction. Annu Rev Microbiol 2019;73:529–57.
    1. World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. . Published February 11, 2020.
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.
    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199–207.
    1. Berger RE. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. J Urol 2005;174:941–2.
    1. Falbo R, Sala MR, Signorelli S, Venturi N, Signorini S, Brambilla P. Bacteriuria screening by automated whole-field image-based microscopy reduces the number of urine cultures. J Clin Microbiol 2012;50:1427–9.
    1. Erdman P, Anderson B, Zacko JC, Taylo K, Donaldson K. The accuracy of the Sysmex UF-1000i in urine bacterial detection compared with the standard urine analysis and culture. Arch Pathol Lab Med 2017;141:1540–3.
    1. Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 2020;9:313–9.
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Qu CQ, He JX. et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020; DOI: 10.1056/NEJMoa2002032. [Epub ahead of print].
    1. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514–23.
    1. General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial sixth edition) (2020-02-19). .
    1. Chen N, Zhou M, Dong X, Dong X, Qu J, Gong F. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13.
    1. Wang D, Hu B, Hu C, Zhu J, Liu X, Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. J Am Med Assoc 2020;323:1061–9.
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. J Am Med Assoc 2020; DOI:10.1001/jama.2020.2648. [Epub ahead of print].
    1. Tetro JA. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect 2020;22:72–3.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever